Dr. Matthias Karajannis, MD, MS
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Brain Tumor
Studies Neurofibromatosis
6 reported clinical trials
10 drugs studied
Area of expertise
1Brain Tumor
Stage IV
IDH negative
H3 K27M negative
2Neurofibromatosis
NF2 positive
NF1 positive
Stage IV
Affiliated Hospitals
More about Matthias Karajannis, MD, MS
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Matthias Karajannis, MD, MS has experience with
- Temozolomide
- Bevacizumab
- Irinotecan
- Omburtamab I-131
- INCB7839
- Radiation Therapy
Breakdown of trials Matthias Karajannis, MD, MS has run
Brain Tumor
Neurofibromatosis
Brain Cancer
Glioblastoma
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthias Karajannis, MD, MS specialize in?
Matthias Karajannis, MD, MS focuses on Brain Tumor and Neurofibromatosis. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are IDH negative.
Is Matthias Karajannis, MD, MS currently recruiting for clinical trials?
No, Matthias Karajannis, MD, MS is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Matthias Karajannis, MD, MS has studied deeply?
Yes, Matthias Karajannis, MD, MS has studied treatments such as Temozolomide, Bevacizumab, Irinotecan.
What is the best way to schedule an appointment with Matthias Karajannis, MD, MS?
Apply for one of the trials that Matthias Karajannis, MD, MS is conducting.
What is the office address of Matthias Karajannis, MD, MS?
The office of Matthias Karajannis, MD, MS is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.